Phenylephrine HCl Injection Recalled Due to Sterility Assurance Failure
Nephron Sterile Compounding Center is recalling Phenylephrine HCl Injection syringes nationwide because the manufacturer cannot assure the product met sterility standards required for injectable medications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable drug where sterility cannot be assured. While the hazard presents significant infection risk, no illnesses or injuries are reported, meeting the criteria for Score 3: risk-of-harm product where injury has not yet been reported.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Phenylephrine HCl Injection, USP (1 mg/10 mL) syringes distributed nationwide due to a lack of assurance of sterility. The recall affects 585,660 syringes across multiple lot numbers with expiration dates from May 2022 through September 2022.
Sterility is a critical requirement for injectable medications. The manufacturer was unable to provide assurance that the affected product met required sterility standards, prompting this recall.
Patients and healthcare providers in possession of affected syringes should not use them. Contact a healthcare provider if the recalled medication has already been administered. Return unused syringes to your pharmacy or healthcare facility for proper disposal.
The recalled product
- Product
- Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Pre-Filled Syringe, 5 x 10 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-957-10
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Compounded Injectable
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lots: PE1115B
- PE1115C
- Exp. 5/31/2022
- PE1122A
- Exp. 6/19/2022
- PE2004B
- PE2004C
- Exp. 7/11/2022
- PE2011A
- PE2011C
- Exp. 8/22/2022
- PE2015A
- PE2015B
- PE2015C
- Exp. 9/5/2022
- PE2016A
- PE2016B
- PE2016C
- Exp. 9/13/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27